Search Within

Sam Yoon

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (8)
  3. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (26)
  2. Surgery (25)
  3. Department of Medicine (23)
  4. Solid Tumor Oncology Division (23)
  5. Melanoma Disease Management Team (19)
  6. Hematologic Malignancies, Division of (18)

More Groups

People
  1. Laura Tang (15)
  2. Vivian Strong (15)
  3. Daniel Coit (14)
  4. Yelena Janjigian (12)
  5. Samuel Singer (11)
  6. Aimee Crago (10)

More People

Years
  1. 2023 (3)
  2. 2022 (3)
  3. 2021 (8)
  4. 2020 (3)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Annals of Surgery (6)
  2. Annals of Surgical Oncology (6)
  3. Journal of Clinical Oncology (6)
  4. Clinical Cancer Research (2)
  5. British Journal of Surgery (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. Springer (7)
  2. American Society of Clinical Oncology (6)
  3. Lippincott Williams & Wilkins (6)
  4. American Association for Cancer Research (3)
  5. American Medical Association (2)
  6. Nature Publishing Group (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histologic subtype defines the risk and kinetics of recurrence and death for primary extremity/truncal liposarcoma
    Journal Article

    Bartlett, E. K.; Curtin, C. E.; Seier, K.; Qin, L. X.; Hameed, M.; Yoon, S. S.; Crago, A. M.; Brennan, M. F.; Singer, S.
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of early-onset versus average-onset esophagogastric cancer
    Meeting Abstract

    Lumish, M. A.; Sabwa, S.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; Joshi, S. S.; Gu, P.; Strong, V. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Comparison of gastric and gastroesophageal junction adenocarcinoma in 2,194 patients
    Meeting Abstract

    Nakauchi, M.; Vos, E.; Carr, R.; Barbetta, A.; Tang, L.; Gonen, M.; Russo, A.; Janjigian, Y.; Yoon, S.; Rusch, V.; more...
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Outcome of 1000 patients with gastrointestinal stromal tumor (GIST) treated by surgery in the pre- and post-imatinib eras
    Journal Article

    Cavnar, M. J.; Seier, K.; Curtin, C.; Balachandran, V. P.; Coit, D. G.; Yoon, S. S.; Crago, A. M.; Strong, V. E.; Tap, W. D.; Gönen, M.; more...
    Annals of Surgery (2021)

    Fulltext@MSK | Save
  • Indications for total gastrectomy in CDH1 mutation carriers and outcomes of risk-reducing minimally invasive and open gastrectomies
    Journal Article

    Vos, E. L.; Salo-Mullen, E. E.; Tang, L. H.; Schattner, M.; Yoon, S. S.; Gerdes, H.; Markowitz, A. J.; Mandelker, D.; Janjigian, Y.; Offitt, K.; more...
    JAMA Surgery (2020)

    Fulltext@MSK | Save
  • A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B.; Crago, A. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Objective response rate among patients with locally advanced or metastatic sarcoma treated with talimogene laherparepvec in combination with pembrolizumab: A phase 2 clinical trial
    Journal Article

    Kelly, C. M.; Antonescu, C. R.; Bowler, T.; Munhoz, R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Dholakia, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Lauren histologic type is the most important factor associated with pattern of recurrence following resection of gastric adenocarcinoma
    Journal Article

    Lee, J. H.; Chang, K. K.; Yoon, C.; Tang, L. H.; Strong, V. E.; Yoon, S. S.
    Annals of Surgery (2018)

    Fulltext@MSK | Save